Treatment outcomes following continuous miglustat therapy in
Por um escritor misterioso
Last updated 04 abril 2025

Background Niemann-Pick disease Type C (NP-C) is a rare, progressive neurodegenerative disorder characterized by progressive neurodegeneration and premature death. We report data at closure of the NPC Registry that describes the natural history, disease course and treatment experience of NP-C patients in a real-world setting. Methods The NPC Registry was a prospective observational cohort study that ran between September 2009 and October 2017. Patients with a confirmed diagnosis of NP-C were enrolled regardless of treatment status. All patients underwent clinical assessments and medical care as determined by their physicians; data were collected through a secure internet-based portal. Results At closure on October 19, 2017, 472 patients from 22 countries were enrolled in the NPC Registry. Mean (standard deviation) age at enrollment was 21.2 (15.0) years, and 51.9% of patients were male. First neurological symptom onset occurred during the early-infantile (< 2 years), late-infantile (2 to < 6 years), juvenile (6 to < 15 years), or adolescent/adult (≥ 15 years) periods in 13.5, 25.6, 31.8, and 29.1% of cases, respectively. The most frequent neurological manifestations prior to enrollment included ataxia (67.9%), vertical supranuclear gaze palsy (67.4%), dysarthria (64.7%), cognitive impairment (62.7%), dysphagia (49.1%), and dystonia (40.2%). During infancy, splenomegaly and hepatomegaly were frequent (n = 199/398 [50%] and n = 147/397 [37.0%], respectively) and persisted in most affected patients. Of the 472 enrolled patients, 241 were continuously treated with miglustat during the NPC Registry observation period, of whom 172 of these 241 patients were treated continuously for ≥12 months. A composite disability score that assesses impairment of ambulation, manipulation, language, and swallowing was highest in the early-infantile population and lowest in the adolescent/adult population. Among the continuous miglustat therapy population, 70.5% of patients had improved or had stable disease (at least 3 of the 4 domains having a decreased or unchanged score between enrollment and last follow-up). The NPC Registry did not identify any new safety signals associated with miglustat therapy. Conclusions The profiles of clinical manifestations in the final NPC Registry dataset agreed with previous clinical descriptions. Miglustat therapy was associated with a stabilization of neurological manifestations in most patients. The safety and tolerability of miglustat therapy was consistent with previous reports.

Safety and efficacy of cipaglucosidase alfa plus miglustat versus

Heat shock protein amplification improves cerebellar myelination

PDF) Treatment outcomes following continuous miglustat therapy in

Precision medicine for genetic childhood movement disorders - Soo

Treatment-emergent adverse events* during 24 months of miglustat

Randomized, controlled trial of miglustat in Gaucher's disease

Correlation of age of onset and clinical severity in Niemann–Pick

Long‐term efficacy of miglustat in paediatric patients with

Cost-effectiveness of miglustat versus symptomatic therapy of

PDF) Treatment outcomes following continuous miglustat therapy in

Long term follow-up to evaluate the efficacy of miglustat

PDF] Review of miglustat for clinical management in Gaucher

Therapies and Upcoming Treatments

Frontiers Therapeutic Strategies For Tay-Sachs Disease
Recomendado para você
-
Niemann Pick Disease Type C - Symptoms, Causes, Treatment04 abril 2025
-
IJMS, Free Full-Text04 abril 2025
-
Niemann-Pick disease type C04 abril 2025
-
PDF] Oxidative Stress: A Pathogenic Mechanism for Niemann-Pick Type C Disease04 abril 2025
-
National Niemann-Pick Disease Foundation, Inc. - October is Global04 abril 2025
-
Diagnostic and predictive methods for a Niemann-Pick disease type04 abril 2025
-
Successful Outcome of Pregnancy in Niemann–Pick Disease Type B: A04 abril 2025
-
Rare Diseases India on X: Niemann-Pick is a rare, inherited04 abril 2025
-
Niemann-Pick Disease Concise Medical Knowledge04 abril 2025
-
10: Types A and B Niemann–Pick Disease04 abril 2025
você pode gostar
-
Análise de Pro Evolution Soccer 201104 abril 2025
-
Resenha The Love You Give Me O Amor Que Me Dá drama chines 202304 abril 2025
-
Stranger Things recap: We rewatched the Netflix series so you don04 abril 2025
-
Tico e Teco Disney phone wallpaper, Cute disney wallpaper, Character wallpaper04 abril 2025
-
Gabe Newell: Image Gallery (List View)04 abril 2025
-
Top 15 Ways to Fix Google Play Store Stuck at Waiting for Download Issue04 abril 2025
-
Lv1 Noob Awakens STRING FRUIT reaches 2nd SEA in BLOXFRUITS04 abril 2025
-
Bandai Ben 10 Alien Swarm Movie Set 1 Sealed New In Box (With Shelf Wear, Dings)04 abril 2025
-
Classroom Of The Elite Anime Characters04 abril 2025
-
Watch “To Your Eternity” Anime Online For Free [All Episodes04 abril 2025